Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.19.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Statement of Cash Flows [Abstract]    
Restricted Cash $ 2,575 $ 0
Net income (loss) [1],[2] 40,340 35,220
Operating Activities:    
Depreciation and amortization [3] 14,259 13,097
Equity (income) loss from equity method investments 250 69
Non-cash debt and financing costs 894 229
Stock-based compensation expense 2,725 4,060
Rent receivable 0 3,077
(Gain) loss on write down and disposal of long-lived assets 960 511
Pension and other post-retirement benefits 1,341 1,274
Change in deferred income taxes [3] 14,895 951
Change in operating assets [3] (15,626) (24,520)
Change in operating liabilities [3] (26,268) (49,330)
Other (57) (488)
Net cash provided by (used in) operating activities [3] 33,713 (15,850)
Investing activities:    
Capital expenditures (37,112) (16,021)
Payments to Acquire Interest in Joint Venture (2,000) 0
Net cash used in investing activities (38,679) (15,249)
Financing activities:    
Proceeds from Issuance of Secured Debt 12,541 0
Proceeds from Hedge, Financing Activities 6,476 0
Finance Lease, Principal Payments (367) 0
Payments of long-term debt 0 (4,313)
Proceeds from exercise of stock options 30 275
Payments of Ordinary Dividends, Common Stock (2,900) 0
Proceeds from Equity Method Investment, Distribution 433 772
Net cash provided by (used in) financing activities 15,780 (4,038)
Net increase (decrease) in cash, cash equivalents and restricted cash 10,814 (35,137)
Effect of foreign currency fluctuations on cash, cash equivalents and restricted cash [3] 1,150 (7,061)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 219,882 244,648
Cash, cash equivalents, and restricted cash, at end of fiscal period $ 217,307 $ 244,648
[1]

[2]
[3]